Related Experiment Videos
Pregnancy termination.
M Bygdeman1, K Gemzell Danielsson, L Marions
1Department of Woman and Child Health, Div. for Obstetrics and Gynecology, Karolinska Hospital, S-171 76, Stockholm, Sweden. astblad@obgyn.ks.se
Steroids
|December 8, 2000
Summary
Mifepristone combined with prostaglandins effectively terminates early and second-trimester pregnancies. This medical abortion regimen is safe, effective, and comparable to surgical methods, offering women an acceptable choice.
Area of Science:
- Reproductive Medicine
- Pharmacology
Background:
- Mifepristone, an antiprogestin, induces uterine contractions and cervical ripening.
- Its efficacy for pregnancy termination is enhanced when combined with prostaglandins.
Purpose of the Study:
- To evaluate the efficacy and safety of mifepristone combined with prostaglandins for pregnancy termination.
- To compare this combined treatment with surgical abortion methods.
Main Methods:
- Administering mifepristone followed by gemeprost or misoprostol for early and second-trimester pregnancy termination.
- Comparing outcomes with vacuum aspiration for early pregnancy termination.
Main Results:
- Combined mifepristone and prostaglandin therapy is effective for early and second-trimester pregnancy termination.
- The regimen is as effective and safe as vacuum aspiration in early pregnancy and equally acceptable to women.
- In the second trimester, it reduces labor duration, prostaglandin dosage, and side effects.
Conclusions:
- Mifepristone-prostaglandin combination is a safe and effective method for medical pregnancy termination.
- This medical approach provides a viable alternative to surgical procedures, with significant benefits in the second trimester.